RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors #AI https://t.co/w8SyenhUgB
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
RT @EricTopol: Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K…
Now a 3rd example of #AI catalyzing drug development efforts. Previous @InSilicoMeds @NatureBiotech https://t.co/O6pwmnrX3K and @deepgenomics https://t.co/InoDJQxp9R New from @exscientialtd entering clinical trial https://t.co/fHVwQKRddf @FT by @madhumita2
先日Deep Learningで開発加速化の論文を出していたところですね。>https://t.co/5H8XZhF5Qr >香港Insilico社と米Pfizer社、AI創薬システム用いた標的分子同定で協力 https://t.co/ogTcXTU89x #日経バイオテクONLINE
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @GalenGrowthAsia: Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/jlgrB0…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/jlgrB0yyXT
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
RT @EricTopol: @DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colle…
@DrHughHarvey Yes, 2, neither yet in clinical trials but are advancing quickly 1. @InSilicoMeds by @biogerontology and colleagues https://t.co/BnfK8VcGek @NatureBiotech 2. @deepgenomics by @frey_brendan and colleagues https://t.co/vCUJ4mALiN not yet publi
RT @JJouglen: La fin des médicaments trop chers?? 🧐 https://t.co/iqZzLjMXI1
La fin des médicaments trop chers?? 🧐
J'ai le sentiment d'avoir ete bloque car j'eprouve des difficultes a acceder au tweet :( ! Heureusement cela ne m'empeche pas de travailler. De @DocCRD et RT par @JJouglen https://t.co/BtGGLn5lJ7
Thomas Tchuss aime bien car il a lu #decouverte :) ! https://t.co/BtGGLn5lJ7
Une étude confirme la capacité de l' #IA à accélérer la découverte de médicaments. La réduction de la durée du cycle complet et du coût global de découverte de molécules actives est la prochaine étape #pharma Etude [UK] https://t.co/IOuzSUqqMb Article [UK]
RT @Mufei_Li: @iwatobipen This one might be the closest: https://t.co/4dXjqg2dZP. But I doubt this has been already deployed in production.
@iwatobipen This one might be the closest: https://t.co/4dXjqg2dZP. But I doubt this has been already deployed in production.
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @DianacBiggs: This is exciting: #AI is making drug discovery a faster process. Congrats @biogerontology on the @nature publication https…
RT @BradReason: Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is im…
RT @NaturalCures5: Great! https://t.co/QwxvvLvOU7
RT @NaturalCures5: Great! https://t.co/QwxvvLvOU7
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
AI, literally obliterating our prior self imposed limitations.The future of AI, continual changing/evolving exponentially in hours. Our current 4 year university systems will helo/coach individuals @CDE, will folks in CA, hurry up and be capable of voting
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @biogerontology: 2019 Year in Pharma by @ACSPublications @cenmag featuring @InSilicoMeds results from our 2018 pilot resulting in @Natur…
RT @biogerontology: 2019 Year in Pharma by @ACSPublications @cenmag featuring @InSilicoMeds results from our 2018 pilot resulting in @Natur…
RT @biogerontology: 2019 Year in Pharma by @ACSPublications @cenmag featuring @InSilicoMeds results from our 2018 pilot resulting in @Natur…
2019 Year in Pharma by @ACSPublications @cenmag featuring @InSilicoMeds results from our 2018 pilot resulting in @NatureBiotech paper. Bigger advances are coming up... https://t.co/xMWmkDAix7 And the paper: https://t.co/cyafxr1ZK5
RT @BradReason: Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is im…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @CBDivaHealth: This is amazingly interesting... and a valuable use for advanced #AI #tech that will be meaningful for the #healthcare of…
RT @CBDivaHealth: This is amazingly interesting... and a valuable use for advanced #AI #tech that will be meaningful for the #healthcare of…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @BradReason: Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is im…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @CBDivaHealth: This is amazingly interesting... and a valuable use for advanced #AI #tech that will be meaningful for the #healthcare of…
RT @thebiomedfuture: 🚀AI identified a drug candidate in 21 days. 🚀Deep learning enables rapid identification of potent DDR1 kinase inhibito…
RT @kaifulee: Fully agree, @EricTopol. AI drug discovery in 46 days! Very encouraging to see the AI empowered breakthrough by our newly add…
RT @MrSmartandDoc: Doctor AI! https://t.co/XlcfDIsMCq
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @BradReason: Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is im…
RT @BradReason: Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is im…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @BradReason: Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is im…
RT @BradReason: Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is im…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @BradReason: Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is im…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…
RT @BradReason: Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is im…
RT @CBDivaHealth: This is amazingly interesting... and a valuable use for advanced #AI #tech that will be meaningful for the #healthcare of…
Scientists at @AstraZeneca publish a Cell paper explaining GENTRL AI better than the original Nature paper and why it is important https://t.co/PRbiEfhCX5 https://t.co/YAURz6PzkB
RT @kylejnorton: @Deloitte published a report on AI-powered drug discovery culminating with AI discovering a drug-like molecule in 46 days.…